UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 281

Sortiert nach

Schnitzler syndrome: validation and applicability of diagnostic criteria in real‐life patients

Allergy (Copenhagen), 2017-02, Vol.72 (2), p.177-182

2017

Volltextzugriff (PDF)

CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2015-12, Vol.67 (12), p.3226-3233

2015

Volltextzugriff (PDF)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

Clinical rheumatology, 2022-05, Vol.41 (5), p.1421-1429

2022

Volltextzugriff (PDF)

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

Annals of the rheumatic diseases, 2005-06, Vol.64 (6), p.913-920

2005

Volltextzugriff (PDF)

Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry Analysis

Arthritis & rheumatology (Hoboken, N.J.), 2016-06, Vol.68 (6), p.1346-1352

2016

Volltextzugriff (PDF)

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Annals of the rheumatic diseases, 2012-11, Vol.71 (11), p.1815-1819

2012

Volltextzugriff (PDF)

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren’s syndrome

Annals of the rheumatic diseases, 2007-01, Vol.66 (1), p.23-27

2007

Volltextzugriff (PDF)

Gammaglobulins, autoantibodies, therapeutic antibodies and anti‐drug antibodies in rheumatoid arthritis

Clinical and experimental immunology, 2014-12, Vol.178 (S1), p.115-117

Gottenberg, J.‐E.

2014

Volltextzugriff (PDF)

B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren's Syndrome

Scandinavian journal of immunology, 2008-02, Vol.67 (2), p.185-192

2008

Volltextzugriff (PDF)

Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry

Annals of the rheumatic diseases, 2012-01, Vol.71 (1), p.84-87

2012

Volltextzugriff (PDF)

Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry

Arthritis care & research (2010), 2013-11, Vol.65 (11), p.1874-1879

2013

Volltextzugriff (PDF)

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling

Genes and immunity, 2010-07, Vol.11 (5), p.432-438

2010

Volltextzugriff (PDF)

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry

Arthritis care & research (2010), 2010-12, Vol.62 (12), p.1787-1795

2010

Volltextzugriff (PDF)

Primary Sjögren's syndrome: Pathophysiological, clinical and therapeutic advances

Joint, bone, spine : revue du rhumatisme, 2009-12, Vol.76 (6), p.591-594

Gottenberg, J.-E

2009

Volltextzugriff (PDF)

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients

Arthritis care & research (2010), 2013-08, Vol.65 (8), p.1358-1364

2013

Volltextzugriff (PDF)

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts

Arthritis & rheumatology (Hoboken, N.J.), 2017-01, Vol.69 (1), p.35-45

2017

Volltextzugriff (PDF)

Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity

Annals of the rheumatic diseases, 2009-07, Vol.68 (7), p.1208-1212

2009

Volltextzugriff (PDF)

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2016-04, Vol.68 (4), p.977-985

2016

Volltextzugriff (PDF)

Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome

Annals of the rheumatic diseases, 2005-01, Vol.64 (1), p.114-117

2005

Volltextzugriff (PDF)

Prise en charge du risque de réactivation du virus de l’hépatite B chez les patients traités par immunosuppresseurs et immunomodulateurs en médecine interne : données de l’enquête REACTI-B et proposition d’un algorithme de prise en charge

La revue de medecine interne, 2012, Vol.33 (1), p.4-12

2012

Volltextzugriff (PDF)

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry

Annals of the rheumatic diseases, 2010-02, Vol.69 (2), p.471-472

2010

Volltextzugriff (PDF)

Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren’s syndrome

Annals of the rheumatic diseases, 2005-07, Vol.64 (7), p.1050-1055

2005

Volltextzugriff (PDF)

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.979-984

2015

Volltextzugriff (PDF)

No evidence for association between 1858 C T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome

Genes and immunity, 2005-08, Vol.6 (5), p.457-458

2005

Volltextzugriff (PDF)

OP0114 Inefficacy of Hydroxychoroquine in Primary Sjögren’s Syndrome: Results at 12 Months of the Randomized Placebo-Controlled Trial of Plaquenil in Primary Sjögren’s Syndrome

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A90-A90

2013

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(257)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(96)
Humans
(86)
Rheumatology
(75)
Female
(64)
Male
(56)
Middle Aged
(54)
Life Sciences
(44)
Medicin Och Hälsovetenskap
(38)
Adult
(36)
Aged
(36)
Rheumatoid Arthritis
(31)
Arthritis, Rheumatoid - Drug Therapy
(23)
Human Health And Pathology
(23)
Immunology
(23)
Antirheumatic Agents - Therapeutic Use
(22)
Treatment Outcome
(22)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Registries
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Schnitzler syndrome: validation and applicability of diagnostic criteria in real‐life patients

CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

Brief Report: Association of Rheumatoid Factor and Anti–Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan‐European Registry Analysis

Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry

Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren’s syndrome

Gammaglobulins, autoantibodies, therapeutic antibodies and anti‐drug antibodies in rheumatoid arthritis

B-cell Activating Factor of the Tumour Necrosis Factor Family Expression in Blood Monocytes and T Cells from Patients with Primary Sjögren's Syndrome

Efficacy of rituximab in primary Sjögren's syndrome with peripheral nervous system involvement: results from the AIR registry

Safety of Surgery After Rituximab Therapy in 133 Patients With Rheumatoid Arthritis: Data From the AutoImmunity and Rituximab Registry

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling

Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: Data from the French Autoimmunity and Rituximab registry

Primary Sjögren's syndrome: Pathophysiological, clinical and therapeutic advances

European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient‐Reported Index: A Complete Picture of Primary Sjögren's Syndrome Patients

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts

Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren’s syndrome

Prise en charge du risque de réactivation du virus de l’hépatite B chez les patients traités par immunosuppresseurs et immunomodulateurs en médecine interne : données de l’enquête REACTI-B et proposition d’un algorithme de prise en charge

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry

Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren’s syndrome

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study

No evidence for association between 1858 C T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome

OP0114 Inefficacy of Hydroxychoroquine in Primary Sjögren’s Syndrome: Results at 12 Months of the Randomized Placebo-Controlled Trial of Plaquenil in Primary Sjögren’s Syndrome

Suchergebnisse filtern